ZD-0892
Modify Date: 2024-02-18 10:51:21
ZD-0892 structure
|
Common Name | ZD-0892 | ||
|---|---|---|---|---|
| CAS Number | 171964-73-1 | Molecular Weight | 499.52 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C24H32F3N3O5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of ZD-0892ZD-0892 is a selective and potent inhibitor of a neutrophil elastase with Kis of 6.7 and 200 nM for human neutrophil elastase and porcine pancreatic elastase, respectively. |
| Name | ZD-0892 |
|---|
| Description | ZD-0892 is a selective and potent inhibitor of a neutrophil elastase with Kis of 6.7 and 200 nM for human neutrophil elastase and porcine pancreatic elastase, respectively. |
|---|---|
| Related Catalog | |
| Target |
Ki: 6.7 nM (Human neutrophil elastase), 200 nM (Human neutrophil elastase)[1] |
| In Vivo | ZD0892 administration to DBA/2 mice infected with the EMC virus results in reduced myocardial elastolytic activity and coronary microvascular perfusion injury. ZD0892 decreases the pathologic severity of the myocardial lesions associated with murine viral myocarditis[1]. ZD-0892 can reverse advanced pulmonary vascular disease produced in rats[2]. |
| Animal Admin | Rats[2] Adult male Sprague-Dawley rats (250-300 g in body weight) are induced pulmonary hypertension. In addition to a group of untreated rats, the experimental groups include rats that receive twice-daily gavage tube feedings of ZD0892, at a dose of 240 mg/kg per day or vehicle (5% polyethylene glycol or dimethyl sulfoxide). Rats are examined after 7 days of treatment. Mice[1] DBA/2 male mice 8 weeks old is used. ZD0892 is given in a dose of 60 mg/kg or 120 mg/kg[1]. |
| References |
| Molecular Formula | C24H32F3N3O5 |
|---|---|
| Molecular Weight | 499.52 |